222 related articles for article (PubMed ID: 19333168)
1. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
Wasan AD; Butler SF; Budman SH; Fernandez K; Weiss RD; Greenfield SF; Jamison RN
Clin J Pain; 2009; 25(3):193-8. PubMed ID: 19333168
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in risk factors for aberrant prescription opioid use.
Jamison RN; Butler SF; Budman SH; Edwards RR; Wasan AD
J Pain; 2010 Apr; 11(4):312-20. PubMed ID: 19944648
[TBL] [Abstract][Full Text] [Related]
4. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
Jamison RN; Ross EL; Michna E; Chen LQ; Holcomb C; Wasan AD
Pain; 2010 Sep; 150(3):390-400. PubMed ID: 20334973
[TBL] [Abstract][Full Text] [Related]
5. The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving.
Martel MO; Dolman AJ; Edwards RR; Jamison RN; Wasan AD
J Pain; 2014 Jan; 15(1):90-100. PubMed ID: 24295876
[TBL] [Abstract][Full Text] [Related]
6. Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial.
Wasan AD; Ross EL; Michna E; Chibnik L; Greenfield SF; Weiss RD; Jamison RN
J Pain; 2012 Feb; 13(2):146-54. PubMed ID: 22245713
[TBL] [Abstract][Full Text] [Related]
7. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
Butler SF; Budman SH; Fanciullo GJ; Jamison RN
Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
[TBL] [Abstract][Full Text] [Related]
8. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
9. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.
Fleming MF; Davis J; Passik SD
Pain Med; 2008 Nov; 9(8):1098-106. PubMed ID: 18721174
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
[TBL] [Abstract][Full Text] [Related]
11. Suicidal ideation is associated with individual differences in prescription opioid craving and cue-reactivity among chronic pain patients.
Garland EL; Riquino MR; Priddy SE; Bryan CJ
J Addict Dis; 2017; 36(1):23-29. PubMed ID: 27644963
[TBL] [Abstract][Full Text] [Related]
12. Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.
Garland EL; Howard MO
Drug Alcohol Depend; 2014 Nov; 144():283-7. PubMed ID: 25282309
[TBL] [Abstract][Full Text] [Related]
13. Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy.
Martel MO; Finan PH; McHugh RK; Issa M; Edwards RR; Jamison RN; Wasan AD
Drug Alcohol Depend; 2016 May; 162():130-6. PubMed ID: 27021805
[TBL] [Abstract][Full Text] [Related]
14. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain.
Dowling LS; Gatchel RJ; Adams LL; Stowell AW; Bernstein D
J Opioid Manag; 2007; 3(5):257-66. PubMed ID: 18181380
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the Current Opioid Misuse Measure.
Butler SF; Budman SH; Fernandez KC; Houle B; Benoit C; Katz N; Jamison RN
Pain; 2007 Jul; 130(1-2):144-56. PubMed ID: 17493754
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse.
Garland EL; Hanley AW; Bedford CE; Zubieta JK; Howard MO; Nakamura Y; Donaldson GW; Froeliger B
J Addict Dis; 2018; 37(1-2):14-22. PubMed ID: 29863439
[No Abstract] [Full Text] [Related]
18. Prescription opioid aberrant behaviors: a pilot study of sex differences.
Back SE; Payne RA; Waldrop AE; Smith A; Reeves S; Brady KT
Clin J Pain; 2009; 25(6):477-84. PubMed ID: 19542794
[TBL] [Abstract][Full Text] [Related]
19. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
20. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain.
Dobscha SK; Morasco BJ; Duckart JP; Macey T; Deyo RA
Clin J Pain; 2013 Feb; 29(2):102-8. PubMed ID: 23269280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
